Business

Neurim Pharmaceuticals markets its new drugs through strategic alliances with reputable marketing and distribution partners on whose marketing expertise we rely.

Neurim has so far established marketing and sales agreements with Teva, Takeda, Aspen Pharmacare, DKSH, Flynn, Medice, Italfarmaco, Biocodex, Kuhnil Pharm, Fidia, Juste and Biopas.
We are actively seeking additional strategic alliances.

Please feel free to contact us:

Dr. Hansjoerg Jakubetz
Director Corporate Business Development
Email: business@neurim.com

  • Text size: A A A
  • Circadin
  • Recent news

    • Circadin® 2mg (prolonged-release melatonin) is now funded for insomnia in children and adolescents with Neurodevelopmental Disorders in New Zealand
    • Circadin® 2mg (prolonged-release melatonin) is now commercially available in Argentina
    • Neurim Pharmaceuticals Grants Exeltis Marketing Rights for Paediatric Prolonged-Release Melatonin (“PedPRM”) in Spain
  • Partners

    Partners